183
Views
53
CrossRef citations to date
0
Altmetric
Research Article

Prostaglandin-Metabolizing Enzymes During Pregnancy: Characterization of NAD+-Dependent Prostaglandin Dehydrogenase, Carbonyl Reductase, and Cytochrome P450-Dependent Prostaglandin Omega-Hydroxylase

&
Pages 101-126 | Published online: 26 Sep 2008

References

  • Aizawa Y., Inazu N., Kogo H. Ca-tabolism of prostaglandin F2αin rat ovary: differences between ovarian and uterine tissues. Prostaglandins 1980; 20: 95–103
  • Agins A. P., Thomas J. J., Edmonds C. G., McClosky J. A. Identification of 12-keto-5,8,10-heptadecatrienoic acid as an arachidonic acid metabolite produced by human HL-60 leukemia cells. Biochem. Pharmacol. 1985; 36: 1799–1805
  • Alam N. A., Russell P. T., Tabor M. W., Moulton B. C. Progesterone and estrogen control of uterine prostaglandin dehydro-genase activity during deciduomal growth. Endocrinology 1976; 98: 859–863
  • Aunggard E., Larsson C., Samuelsson B. The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin-δ13-reductase in tissues of the swine. Acta Physiol. Scand. 1971; 81: 396–404
  • Auletta F. J., Kamps D. L., Wesley M., Gibson M. Luteolysis in the rhesus monkey: ovarian venous estrogen, progesterone, and prostaglandin F2α-metabolite. Prostaglandins 1984; 27: 299–310
  • Baker M. E. Sequence analysis of steroid-and prostaglandin-metabolizing enzymes: application to understanding catalysis. Steroids 1994; 59: 248–258
  • Bedwani J. R., Marley P. B. Enhanced inactivation of prostaglandin E2by the rabbit lung during pregnancy or progesterone treatment. Br. J. Pharmacol 1975; 53: 547–554
  • Bergholte J. M., Okita R. T. Purification and characterization of lung 15-hydroxy-prostaglandin dehydrogenase. Arch. Biochem. Biophys. 1986a; 245: 308–315
  • Bergholte J. M., Okita R. T. Characterization of an endogenous inhibitor of lung 15-hydroxyprostaglandin dehydrogenase. Biochim. Biophys. Acta 1986b; 879: 164–170
  • Bergholte J. M., Soberman R. J., Hayes R., Murphy R. C., Okita R. T. Oxidation of 15-hydroxyeicosatetraenoic acid and other hydroxy fatty acids by lung prostaglan-din dehydrogenase. Arch. Biochem. Biophys. 1987; 257: 444–450
  • Berry C. N., Hoult J. R. S., Peers S. H., Agback H. Inhibition of prostaglandin 15-hydroxydehydrogenase by sulphasalazine and a novel series of potent analogues. Biochem. Pharmacol. 1983; 32: 2863–2871
  • Berry C. N., Hoult J. R. S., Phillips J. A., McCarthy T. M., Agback H. Highly potent inhibition of prostaglandin 15-hydroxydehydrogenasein vitroand of prostaglandin inactivation in perfused lung by the new azobenzene analogue, Ph CL 28A. J. Pharm. Pharmacol. 1985; 37: 622–628
  • Braithwaite S. S., Jarabak J. Studies on a 15-hydroxyprostaglandin dehydrogenase from human placenta. Purification and partial characterization. J. Biol. Chem. 1975; 250: 2315–2318
  • Carroll M. A., Sala A., Dunn C. E., McGiff J. C., Murphy R. C. Structural identification of cytochrome P450-dependent arachi-donate metabolites formed by rabbit medullary thick ascending limb cells. J. Biol. Chem. 1991; 266: 12306–12312
  • Casey M. L., Delgadillo M., Cox K. A., Niesert S., MacDonald P. C. Inactivation of prostaglandins in human decidua vera (parietalis) tissue: substrate specificity of prostaglandin dehydrogenase. Am. J. Obstet. Gynecol. 1989; 160: 3–7
  • Casey M. L., Hemsell D. L., MacDonald P. C., Johnston J. M. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activity in human endometrium. Prostaglandins 1980; 19: 115–122
  • Chang W.-C. Effects of steroids on renal NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activity in ovariectomized rats. Prostaglandins Leukotrienes Med. 1987; 29: 25–32
  • Chang W.-C., Fukuda S., Tai H.-H. Pulmonary NAD+-linked 15-hydroxyprostaglandin dehydrogenase activity is decreased by cigarette smoking. Life Sci. 1984; 34: 1261–1268
  • Chang W.-C., Tai H.-H. Induction of a decrease in renal NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activity by estradiol in rats. Biochem. Pharmacol 1985; 34: 2073–2076
  • Chang W. C., Wu H. L., Hsu S. Y., Chen F. S. Isolation of rat renal NAD+-dependent 15-hydroxyprostaglandin dehydrogenase. Prostaglandins Leukotrienes Essent. Fatty Acids 1990; 41: 19–25
  • Chavan A. J., Ensor C. M., Wu P., Haley B. E., Tai H.-H. Photoaffinity labeling of human placental NAD+-linked 15-hydroxyprostaglandin dehydrogenase with [α-32P]2 N3NAD+. J. Biol. Chem. 1993; 268: 16437–16442
  • Cheung P. Y. C., Walton J. C., Tai H.-H., Riley S. C., Challis J. R. G. Immunocy-tochemical distribution and localization of 15-hydroxyprostaglandin dehydrogenase in human fetal membranes, decidua, and placenta. Am. J. Obstet. Gynecol. 1990; 163: 1445–1449
  • Devereux T. R., Fouts J. R., Eling T. E. Metabolism of prostaglandin PG-F2αby freshly isolated alveolar type II cells from lungs of adult male and pregnant rabbits. Prostaglandins Leukotrienes Med. 1987; 27: 43–52
  • Diczfalusy U., Falardeau P., Hammarström S. Conversion of prostaglandin endo-peroxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase. FEBS Lett. 1977; 84: 271–274
  • Earles S. M., Bomstein J. C., Winner D. L., Bull A. W. Metabolism of oxidized linoleic acid: characterization of 13-hydroxy-octadecadienoic acid dehydrogenase activity from rat colonic tissue. Biochim. Biophys. Acta 1991; 1081: 174–180
  • Edgerton-Vernon J. M., Bedwani J. R. Prostaglandin 15-hydroxydehydrogenase activity during pregnancy in rabbits and rats. Eur. J. Pharmacol. 1975; 33: 405–408
  • Ensor C. M., Tai H.-H. Site-directed mutagenesis of the conserved tyrosine 151 of human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase yields a catalytically inactive enzyme. Biochem. Biophys. Res. Commun. 1991; 176: 840–845
  • Ensor C. M., Tai H.-H. Expression of the cDNA for NAD+-dependent 15-hydroxy-prostaglandin dehydrogenase as a catalytically active enzyme i. Escherichia coli. Prostag-landins Leukotrienes Essent. Fatty Acids 1992; 46: 219–222
  • Ensor M. C., Yang J.-Y., Okita R. T., Tai H.-H. Cloning and sequence analysis of the cDNA for human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). J. Biol. Chem. 1990; 265: 14888–14891
  • Erman A., Pitcock J. A., Liston T., Brown P., Baer P. G., Nasjletti A. Biphasic effect of dexamethasone on urinary prostag-landins in rats: relation to alterations in renal medulla triglycerides and prostaglandin metabolism. Endocrinology 1987; 121: 1853–1861
  • Escalante B., Erlij D., Falck J. R., McGiff J. C. Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am. J, Physiol. 1994; 266: C1775–C1782
  • Escalante B., Sessa W. C., Falck J. R., Yadagiri P., Schwartzman M. L. Cytochrome P450-dependent arachidonic acid metabolites, 19- and 20-hydroxyeicosatetraenoic acids, enhance sodium-potassium ATPase activity in vascular smooth muscle. J. Cardio-vasc. Pharmacol. 1990; 16: 438–443
  • Falkay G., Sas M. Correlation between the concentrations of prostaglandin dehydrogenase and progesterone in the early human placenta. J. Endocrinol. 1978; 76: 173–174
  • Granström E., Samuelsson B. On the metabolism of prostaglandin F2αin female subjects. J. Biol. Chem. 1971a; 246: 5254–5263
  • Granström E., Samuelsson B. On the metabolism of prostaglandin F2αin female subjects. II. Structures of six metabolites. J. Biol. Chem. 1971b; 246: 7470–7485
  • Hamberg M., Samuelsson B. On the metabolism of prostaglandin F2αin man. J. Biol. Chem. 1971; 246: 6713–6721
  • Hansen H. S. 15-Hydroxyprostaglandin dehydrogenase. Prostaglandins 1976; 12: 647–679
  • Hecker M., Ullrich V. 12(S)-Hydroxy-5,8,10 (Z,E,E)-heptadecatrienoic acid (HHT) is preferentially metabolized to its 12-keto derivative by human erythrocytes. in vitro. Eicosarioids 1988; 1: 19–25
  • Hill E., Fitzpatrick F., Murphy R. C. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet. Br. J. Pharmacol 1992; 106: 267–274
  • Höhl W., Stahl B., Mundkowski R., Hofmann U., Meese C. O., Kuhlmann U., Schlegel W. Mass determination of 15-hydroxyprostaglandin dehydrogenase from human placenta and kinetic studies with (5Z, 8E, 10E, 12S)-12-hydroxy-5,8,10-hepta-decatrienoic acid as substrate. Eur. J. Biochenu 1993; 214: 67–73
  • Holtzman M. J. Arachidonic acid metabolism: implications of biological chemistry for lung function and disease. Am. Rev. Respir. Dis. 1991; 143: 188–203
  • Hoult J. R. S., Bacon K. B., Osborne D. J., Robinson C. Organ selective conversion of prostaglandin D2to 9α, 11β-prosta-glandin F2and its subsequent metabolism in rat, rabbit and guinea pig. Biochem. Pharmacol. 1988; 37: 3591–3599
  • Inazu N., Kago H., Gizawa Y. Stimulation of the formation of 13,14-dihydro-prostaglandin F2by gonadotropin in rat ovary. Biochem. Biophys. Acta 1983; 750: 98–104
  • Iwata N., Inazu N., Satoh T. The purification and properties of NADPH-depen-dent carbonyl reductases from rat ovary. J. Biochem. 1989; 105: 556–564
  • Iwata N., Inazu N., Satoh T. Immu-nological and enzymological localization of carbonyl reductase in ovary and liver of various species. J. Biochem. 1990a; 107: 209–212
  • Iwata N., Inazu N., Satoh T. Changes and localization of ovarian carbonyl reductase during pseudopregnancy and pregnancy in rats. Biol Reprod. 1990b; 43: 397–403
  • Jarabak J. Early steps in prostaglandin metabolism in the human placenta. Am. J. Obstet. Gynecol. 1980; 138: 534–540
  • Jarabak J. Polycyclic aromatic hydrocarbon quinones may be either substrates for or irreversible inhibitors of the human placental NAD-linked 15-hydroxyprostaglandin dehy-drogenase. Arch. Biochem. Biophys. 1992; 292: 239–243
  • Jarabak J., Berkowitz D., Sun F. Oxidation of prostacyclin and its analogs by three 15-hydroxyprostaglandin dehydrogena-ses. Prostaglandins 1984; 28: 509–516
  • Jarabak J., Watkins J. D. Purification of the human placental NAD-linked 15-hydroxyprostaglandin dehydrogenase. Prostaglandins 1988; 36: 205–213
  • Jarabak J., Watkins J. D., Lindheimer M. In vitroactivity of nicotinamide ad-enine dinucleotide- and nicotinamide adenine dinucleotide phosphate-linked 15-hydroxyprostaglandin dehydrogenases in placentas from normotensive and preeclamptic/eclamptic pregnancies. J. Clin. Invest. 1987; 80: 936–940
  • Kehl S. J., Carlson J. C. Assessment of the luteolytic potency of various prostaglandins in the pseudopregnant rabbit. J. Reprod. Fertil. 1981; 62: 117–122
  • Keirse M. J.N.C., Erwich J. J.H. M., Klok G. Increase in placental 15-hydroxy-pros-taglandin dehydrogenase in the first half of human pregnancy. Prostaglandins 1985; 30: 131–140
  • Kelly R. W., Taylor P. L., Hearn J. P., Short R. V. 19-Hydroxyprostaglandin E1as a major component of the semen of primates. Nature 1976; 260: 544–545
  • Korff J., Jarabak J. Partial isolation and characterization of the 15-hydroxyprostaglandin dehydrogenases and 9-ketoprosta-glandin reductases in rabbit kidney. Prostaglandins 1980; 20: 111–125
  • Krook M., Ghosh D., Daux W., Jörnvall H. Three-dimensional model of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase and relationships to the NADP+-de-pendent enzyme (carbonyl reductase). FEBS Lett. 1993a; 322: 139–142
  • Krook M., Ghosh D., Strömberg R., Carlquist M., Jörnvall H. Carboxyethyl-lysine in a protein: native carbonyl reductase/NADP+-dependent 15-prostaglandin dehydrogenase. Proc. Natl. Acad. Sci. U.S.A. 1993b; 90: 502–506
  • Krook M., Marekov L., Jörnvall H. Purification and structural characterization of placental NAD+-linked 15-hydroxy-prostag-landin dehydrogenase. The primary structure reveals the enzyme to belong to the short-chain alcohol dehydrogenase family. Biochemistry 1990; 29: 738–743
  • Krook M., Prozorovski V., Atrian S., Gonzalez-Duarte R., Jörnvall H. Short-chain dehydrogenases. Proteolysis and chemical modification of prokaryotic 3α/20β-hydroxy-steroid, insect alcohol and human 15-hydroxyprostaglandin dehydrogenases. Eur. J. Biochem. 1992; 209: 233–239
  • Kumlin M., Hamberg M., Granström E., Björck T., Dahlén B., Matsuda H., Zetterström O., Dahlén S.-E. 15-(S)-Hydroxy-eicosatetraenoic acid is the major arachidonic acid metabolite in human bronchi: association with airway epithelium. Arch. Biochem. Biophys. 1990; 282: 254–262
  • Kung-Chao D. T.-Y., Tai H.-H. NAD+-hydroxyprostaglandin dehydrogenase from porcine kidney. I. Purification and partial characterization. Biochim. Biophys. Acta 1980; 614: 1–13
  • Leithauser M. T., Roering D. L., Winquist S. M., Gee A., Okita R. T., Masters B. S. S. Omega-hydroxylation of pros-taglandin E1in the isolated perfused lungs of pregnant rabbits. Prostaglandins 1988; 36: 819–833
  • Liu Y., Tai H.-H. Inactivation of pulmonary NAD+-dependent 15-hydroxy-prostag-landin dehydrogenase by acrolein. Biochem. Pharmacol. 1985; 34: 4275–4278
  • Liu Y., Yoden K., Shen R.-F., Tai H.-H. 12-L-Itydroxy-5,8,10-heptadecatrienoic acid (HHT) is an excellent substrate for NAD+-dependent 15-hydroxyprostaglandin dehydrogenase. Biochem. Biophys. Res. Comm. 1985; 129: 268–274
  • Ma Y.-H., Schwartzman M. L., Roman R. J. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am. J. Physiol. 1994; 267: R579–R589
  • Mak O. T., Jörnvall H., Jeffery J. The primary prostaglandin-inactivating enzyme of human placenta is a dimeric short-chain dehy-drogenase. Biosci. Rep. 1982; 2: 503–508
  • Mak O. T., Liu Y., Tai H.-H. Purification and characterization of NAD+-depen-dent 15-hydroxyprostaglandin dehydrogenase from porcine kidney. Biochim. Biophys. Acta 1990; 1035: 190–196
  • Marrazzi M. A., Matschinsky F. M. Properties of 15-hydroxyprostaglandin dehydrogenase: structural requirements for substrate binding. Prostaglandins 1972; 1: 373–388
  • Matsubara S., Yamamoto S., Sogawa K., Yokotani N., Fujii-Kuriyama Y., Haniu M., Shively J., Gotoh O., Kusunose E., Kusunose M. cDNA cloning and in-ducible expression during pregnancy of the mRNA for rabbit pulmonary prostaglandin ω-hydroxylase (cytochrome P-450p-2). J. Biol. Chem. 1987; 262: 13366–13371
  • Mucha I., Losonczy G. Prostaglandin E2and gestational hypotension in rabbits. Prostaglandins 1990; 40: 143–153
  • Muerhoff A. S., Williams D. E., Leithauser M. T., Jackson V., Waterman M. R., Masters B. S. S. Regulation of the induction of a cytochrome P-450 prostaglandin ω-hydroxy-lase by pregnancy in rabbit lung. Proc. Natl, Acad. Sci. U.S.A. 1987; 84: 7911–9714
  • Nagai K., Nabekura H., Mibe M., Ohshige T., Mori N. Prostaglandin dehydrogenase activity in placenta and in maternal lung, kidney, and gastric mucosa during rat pregnancy. Mol. Cell. Endocrinol. 1991; 80: 153–163
  • Nagai K., Tsuruta K., Mori N. Purification of an NAD+-dependent 15-hydroxyprostaglandin dehydrogenase from the human placenta. Prostaglandin Leukotrienes Med. 1987; 26: 123–132
  • Nagai K., Tanaka T., Tsuruta K., Mori N. New inhibitor(s) of 15-hydroxy-pros-taglandin dehydrogenase activity in human milk. Am. J. Perinatol 1988; 5: 89–93
  • Nelson D. R., Kamataki T., Waxman D. J., Guen-Gerich F. P., Estabrook R. W., Feyereisen R., Gonzalez F. J., Coon M. J., Gunsalus I. C., Gotoh O., Okuda K., Nebert D. W. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993; 12: 1–51
  • Nelson N. A., Kelly R. C., Johnson R. A. Prostaglandins and the arachidonic acid cascade. Chem. Eng. News 1982; 60: 1–15
  • Nies A. S. Prostaglandins and the control of the circulation. Clin. Pharm. Ther. 1986; 39: 481–488
  • Nishimoto M., Clark J. E., Masters B. S. S. Cytochrome P4504A4: expression inE. coli, purification, and characterization of catalytic properties. Biochemistry 1993; 32: 8863–8870
  • Ohara H., Nakayama T., Deyashiki Y., Hara S., Miyabe Y., Tsukada F. Reduction of prostaglandin D2to 9α, 11 β-prostag-landin F2by a human liver 3α-hydroxysteroid/ dihydrodiol dehydrogenase isozyme. Biochim. Biophys. Acta 1994; 1215: 59–65
  • Oliw E. H., Fahlstadius P., Hamberg M. Isolation and biosynthesis of 20-hydroxyprostaglandins E1and E2in ram seminal fluid. J. Biol. Chem. 1986; 261: 9216–9221
  • Okita J. R., Robertson S. J., Okita R. T. Changes in ovarian NAD+-dependent 15-hydroxyprostaglandin dehydrogenase activity in pregnant and pseudopregnant rabbits. Prostaglandins Leukotrienes Essent. Fatty Acids 1992; 46: 93–98
  • Okita R. T. Effects of peroxisome proliferators on microsomal P450 reactions. Peroxisome Proliferators: Unique Inducers of Drug-Metabolizing Enzymes, D. E. Moody. CRC Press, Boca Raton, FL 1994; 37–49
  • Okita R. T., Sinning A. R., Okita J. R., Tai H.-H., Markwald R. R., Bergholte J. M. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase: immunochemical characterization of the lung enzyme from pregnant rabbits. Arch. Biochem. Biophys. 1990; 279: 242–248
  • Okita R. T., Soberman R. J., Bergholte J. M., Masters B. S. S., Hayes R., Murphy R. C. ω-Hydroxylation of 15-hydroxyeicosa-tetraenoic acid by lung microsomes from pregnant rabbits. Mol. Pharmacol 1987; 32: 706–709
  • Pace-Asciak C. R., Edwards N. S. Distinct age-related changes in the urinary catabolic profile of prostaglandin F2αin the rat. J. Biol. Chem. 1980; 255: 6106–6110
  • Pace-Asciak C. R., Smith W. L. Enzymes in the biosynthesis and catabolism of the eicosanoids: prostaglandins, thromboxanes, leukotrienes, and hydroxy fatty acids. The Enzymes, P. Boyer. Academic Press, New York 1983; Vol. 16: 543–603
  • Palmer C. N. A., Griffin K. J., Johnson E. F. Rabbit prostaglandin ω-hydroxylase (CYP4A4): gene structure and expression. Arch. Biochem. Biophys. 1993; 300: 670–676
  • Patrono C. Arachidonic acid metabolism in the ovary: biochemistry, methodology, and physiology. The Ovary, G. B. Serra. Raven Press, New York 1983; 45–56
  • Pennington S. N., Taylor W. A. Kinetic changes in rat renal 15-hydroxyprosta-glandin dehydrogenase induced by chronic ethanol exposure. Prostaglandins 1983; 25: 291–297
  • Piper P. J., Vane J. R., Wyllie J. H. Inactivation of prostaglandins by the lungs. Nature 1970; 225: 600–604
  • Powell W. S. ω-Oxidation of prostaglandins by lung and liver microsomes. Changes in enzyme activity induced by pregnancy, pseudopregnancy, and progesterone treatment. J. Biol. Chem. 1978; 253: 6711–6717
  • Powell W. S. Distribution of prostaglandin ω-hydroxylases in different tissues. Prostaglandins 1980; 19: 701–710
  • Powell W. S., Hammarström S., Sammuelsson B. Prostaglandin F2αreceptor in ovine corpora lutea. Ear. J. Biochem. 1974; 41: 103–107
  • Powell W. S., Hammarström S., Sammuelsson B. Occurrence and properties of a prostaglandin F2αreceptor in bovine corpora lutea. Eur. J. Biochem. 1975; 56: 73–77
  • Powell W. S., Solomon S. Formation of 20-hydroxyprostaglandins by lungs of pregnant rabbits. J. Biol. Chem. 1978; 253: 4609–4616
  • Pourian M. R., Kvist U., Björndahl L., Oliw E. H. Rapid and slow hydroxylators of seminal E prostaglandins among men in barren unions. Andrologia 1995; 27: 71–79
  • Pugliese G., Spokas E. G., Marcinkiewicz E., Wong P. Y.-K. Hepatic transformation of prostaglandin D2to a new prostanoid, 9α, 11β-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. J. Biol. Chem. 1985; 260: 14621–14625
  • Quayle A. J., Kelly R. W., Hargreave T. B., James K. Immunosuppression by seminal prostaglandins. Clin. Exp. Immunol. 1989; 75: 387–391
  • Randall C. L., Anton R. F., Becker H. C. Alcohol, pregnancy, and prostaglandins. Alcohol. Clin. Exp. Res. 1987; 11: 32–36
  • Roman L. J., Palmer C. N. A., Clark J. E., Muerhoff A. S., Griffin K. J., Johnson E. F., Masters B. S. S. Expression of rabbit cytochromes P4504A which catalyze the ω-hydroxylation of arachidonic acid, fatty acids, and prostaglandins. Arch. Biochem. Biophys. 1993; 307: 57–65
  • Ryan U. Structural bases for metabolic activity. Annual Review of Physiology, I. S. Edelman, R. M. Berne. Annual Reviews, Palo Alto 1982; Vol. 44: 223–239
  • Sakuma S., Fujimoto Y., Yamane K., Nishida H., Fujita T. The effects of arachidonic acid and its CoA ester on the catabolism of prostaglandin E2in rabbit kidney cortex. Biochem. Int. 1992; 27: 291–299
  • Sakuma S., Fujimoto Y., Yamane K., Nishida H., Fujita T. Inhibition of 15-hydroxy prostaglandin dehydrogenase activity in rabbit gastric antral mucosa by 13-hydroxyperoxy-octadecadienoic acid. Prostaglandins Leukotrienes Essent. Fatty Acids 1994; 51: 425–430
  • Sangha R. K., Walton J. C., Ensor C. M., Tai H.-H., Challis J. R. G. Immu-nochemical localization, messenger ribo-nucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor. J. Clin. Endocrinol. Metab. 1994; 78: 982–989
  • Schenker S., Becker H. C., Randall C. L., Phillips D. K., Baskin G. S., Henderson G. I. Fetal alcohol syndrome: current status of pathogenesis. Alcohol. Clin. Exp. Res. 1990; 14: 635–647
  • Schlegel W., Kruger S., Daniels D., Fischer B., Schneider H. P. G., Beier H. M. Studies on prostaglandin metabolism in corporalutea of rabbits during pregnancy and pseudopreg-nancy. J. Reprod Fertil 1988; 83: 365–370
  • Schwartzman M. L., Falck J. R., Yadagiri P., Escalante B. Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxy-genase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites. J. Biol. Chem. 1989; 264: 11658–11662
  • Sigal E., Nadel J. A. The airway epithelium and arachidonic acid 15-lipoxygenase. Am. Rev. Respir. Dis. 1991; 143: S71–s74
  • Sun F. F., Armour S. B. Prostaglandin 15-hydroxy dehydrogenase and δ13reductase levels in the lungs of maternal, fetal and neonatal rabbits. Prostaglandins 1974; 7: 327–338
  • Tai C. L., Mak O. T., Arai T., Tai H.-H. Monoclonal antibodies that inhibit the enzyme activity of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase. Bio-chem. J. 1990; 267: 75–78
  • Tanaka T., Kotani T., Ohtaki S., Nagai K., Tsuruta K., Mori N. Labile oligo-meric structure of human placental 15-hydroxy-prostaglandin dehydrogenase. Biochem. Biophys. Res. Commun. 1986; 135: 1058–1063
  • Treissman D., Brien J. F. Fetal guinea pig brain 15-hydroxyprostaglandin dehydrogenase: ontogeny and effect of ethanol. Ethanol 1991; 8: 97–102
  • Treissman D., Smith G. N., Patrick J., Brien J. F. Effect of ethanol on 15-hydroxyprostaglandin dehydrogenase activity in the brain stem of the near-term fetal sheep. Dev. Pharmacol. Ther. 1991; 16: 48–52
  • Venuto R. C., Donker A. J. M. Prostaglandin E2, plasma renin activity, and renal function throughout rabbit pregnancy. J. Lab. Clin. Med. 1982; 99: 239–246
  • Watanabe Y., Yamashita A., Tokumoto H., Hayaishi O. Localization of prostaglandin D2binding protein and NADP-linked 15-hydroxyprostaglandin D2dehydrogenase in the Purkinje cells of miniature pig cerebellum. Proc. Natl. Acad. Sci. U.S.A. 1983; 80: 4542–4545
  • Wermuth B. NADP-dependent 15-hydroxyprostaglandin dehydrogenase is homologous to NAD-dependent 15-hydroxyprostaglandin dehydrogenase and other short-chain alcohol dehydrogenases. Prostaglandins 1992; 44: 5–9
  • Williams D. E., Hale S. E., Okita R. T., Masters B. S. S. A prostaglandin ω-hydroxylase cytochrome P-450 (P-450PG-ω) purified from lungs of pregnant rabbits. J. Biol. Chem. 1984; 259: 14600–14608
  • Wu P., Fritzo M., Tai H.-H. Purification and characterization of an NAD+-depen-dent dehydrogenase that catalyzes the oxidation of thromboxane B2at C-11 from porcine liver. Development and application of 11-dehydro-thromboxane B2radioimmunoassay to enzyme assay. Biochim. Biophys. Acta 1990; 1036: 55–63
  • Xun C.-Q., Ensor C. M., Tai H.-H. Regulation of synthesis and activity of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by dexamethasone and phorbol ester in human erythroleukemia (HEL) cells. Biochem. Biophys. Res. Commun. 1991a; 177: 1258–1265
  • Xun C.-Q., Tian Z.-G., Tai H.-H. Stimulation of synthesisde novoof NAD+-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester. Biochem. J. 1991b; 279: 553–558
  • Yamamoto S., Kusunose E., Matsubara S., Ichihara K., Kusunose M. Occurrence of cytochrome P-450 with prostaglandin ω-hydroxylase activity in rabbit placental micro-somes. J. Biochem. 1986; 100: 175–181
  • Yamamoto S., Kusunose E., Ogita K., Kaku M., Ichihara K., Kusunose M. Isolation of cytochrome P-450 highly active in prostaglandin ω-hydroxylation from lung micro-somes of rabbits treated with progesterone. J. Biochem. 1984; 96: 593–603
  • Zou A.-P., Imig J. D., Kaldunski M., Ortiz De Montellano P., Sui Z., Roman R. J. Inhibition of renal vascular 2-HETE production impairs autoregulation or renal blood flow. Am. J. Physiol. 1994; 266: F273–F282

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.